Canada markets closed

ESSA Pharma Inc. (EPI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
9.550.00 (0.00%)
At close: 9:37AM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 5277.03M
Enterprise Value 3240.64M
Trailing P/E N/A
Forward P/E 1-13.64
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.39
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-10.77

Trading Information

Stock Price History

Beta (5Y Monthly) 1.60
52-Week Change 3144.87%
S&P500 52-Week Change 311.08%
52 Week High 311.34
52 Week Low 33.89
50-Day Moving Average 39.39
200-Day Moving Average 37.43

Share Statistics

Avg Vol (3 month) 37.21k
Avg Vol (10 day) 318.68k
Shares Outstanding 529.01M
Float 15.57M
% Held by Insiders 14.91%
% Held by Institutions 166.95%
Shares Short (Sep. 14, 2020) 41.85k
Short Ratio (Sep. 14, 2020) 40.09
Short % of Float (Sep. 14, 2020) 40.01%
Short % of Shares Outstanding (Sep. 14, 2020) 40.01%
Shares Short (prior month Aug. 13, 2020) 4658

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr. 24, 2018

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Sep. 29, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-61.60%
Return on Equity (ttm)-106.04%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -22.33M
Net Income Avi to Common (ttm)-19.91M
Diluted EPS (ttm)-1.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)36.48M
Total Cash Per Share (mrq)1.26
Total Debt (mrq)87.28k
Total Debt/Equity (mrq)0.24
Current Ratio (mrq)29.77
Book Value Per Share (mrq)1.77

Cash Flow Statement

Operating Cash Flow (ttm)-17.7M
Levered Free Cash Flow (ttm)-9.36M